ZNF345
gene geneOn this page
Also known as HZF10
Summary
ZNF345 (zinc finger protein 345, HGNC:16367) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 345 (Q14585). May be involved in transcriptional regulation.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 25850 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 34 total
- MANE Select transcript:
NM_001242472
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16367 |
| Approved symbol | ZNF345 |
| Name | zinc finger protein 345 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HZF10 |
| Ensembl gene | ENSG00000251247 |
| Ensembl biotype | protein_coding |
| OMIM | 621272 |
| Entrez | 25850 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 29 protein_coding, 5 protein_coding_CDS_not_defined
ENST00000331800, ENST00000420450, ENST00000432005, ENST00000525851, ENST00000526123, ENST00000529555, ENST00000529989, ENST00000532141, ENST00000534729, ENST00000585396, ENST00000586646, ENST00000586933, ENST00000589046, ENST00000706174, ENST00000868513, ENST00000868514, ENST00000868515, ENST00000868516, ENST00000868517, ENST00000868518, ENST00000868519, ENST00000868520, ENST00000868521, ENST00000868522, ENST00000914790, ENST00000914791, ENST00000914792, ENST00000914793, ENST00000963970, ENST00000963971, ENST00000963972, ENST00000963973, ENST00000963974, ENST00000963975
RefSeq mRNA: 5 — MANE Select: NM_001242472
NM_001242472, NM_001242474, NM_001242475, NM_001242476, NM_003419
CCDS: CCDS12497
Canonical transcript exons
ENST00000420450 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001681945 | 36876785 | 36879575 |
| ENSE00001705454 | 36851830 | 36851904 |
| ENSE00002821052 | 36850876 | 36850968 |
Expression profiles
Bgee: expression breadth ubiquitous, 187 present calls, max score 89.05.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.0752 / max 94.3440, expressed in 1312 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175530 | 3.3009 | 1184 |
| 175529 | 0.6903 | 373 |
| 175528 | 0.0743 | 21 |
| 175531 | 0.0096 | 3 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 89.05 | gold quality |
| left testis | UBERON:0004533 | 88.65 | gold quality |
| testis | UBERON:0000473 | 84.81 | gold quality |
| sperm | CL:0000019 | 83.63 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.33 | gold quality |
| colonic epithelium | UBERON:0000397 | 82.26 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.72 | gold quality |
| cortical plate | UBERON:0005343 | 80.84 | gold quality |
| male germ cell | CL:0000015 | 80.80 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.04 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.65 | gold quality |
| right ovary | UBERON:0002118 | 78.29 | gold quality |
| popliteal artery | UBERON:0002250 | 78.13 | gold quality |
| tibial artery | UBERON:0007610 | 78.13 | gold quality |
| ventricular zone | UBERON:0003053 | 78.00 | gold quality |
| left ovary | UBERON:0002119 | 77.70 | gold quality |
| aorta | UBERON:0000947 | 77.31 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 77.01 | gold quality |
| tibial nerve | UBERON:0001323 | 76.82 | gold quality |
| lower esophagus | UBERON:0013473 | 76.53 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 76.52 | gold quality |
| thoracic aorta | UBERON:0001515 | 76.45 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 76.45 | gold quality |
| ascending aorta | UBERON:0001496 | 76.39 | gold quality |
| right lung | UBERON:0002167 | 76.33 | gold quality |
| body of uterus | UBERON:0009853 | 76.32 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 76.32 | gold quality |
| mucosa of stomach | UBERON:0001199 | 76.31 | gold quality |
| right coronary artery | UBERON:0001625 | 76.31 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.23 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.12 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
105 targeting ZNF345, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp11 | ENSMUSG00000051034 |
| rattus_norvegicus | Zfp11 | ENSRNOG00000051442 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 345 — Q14585 (reviewed: Q14585)
Alternative names: Zinc finger protein HZF10
All UniProt accessions (7): E9PLT7, Q14585, F8W8R5, K7EKZ8, K7EM63, K7EQ01, K7ESK8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (5): NP_001229401, NP_001229403, NP_001229404, NP_001229405, NP_003410 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF13465
UniProt features (16 total): zinc finger region 15, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14585-F1 | 81.72 | 0.57 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 73 (showing top):
GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III, MODULE_123, MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY, IL21_UP.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, DYRK1A_TARGET_GENES, ZFP28_TARGET_GENES, ZFP3_TARGET_GENES, ZNF2_TARGET_GENES
GO Biological Process (7): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), regulation of transcription by RNA polymerase III (GO:0006359), transcription by RNA polymerase II (GO:0006366), transcription by RNA polymerase III (GO:0006383), regulation of DNA-templated transcription (GO:0006355), positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 3 |
| DNA-templated transcription | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| negative regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase III | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
376 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF345 | TFPI2 | P48307 | 414 |
| ZNF345 | ZC3H11B | A0A1B0GTU1 | 400 |
| ZNF345 | ZNF608 | Q9ULD9 | 340 |
| ZNF345 | BEST3 | Q8N1M1 | 334 |
| ZNF345 | TFF3 | Q07654 | 324 |
| ZNF345 | CCDC180 | Q9P1Z9 | 322 |
| ZNF345 | BEST2 | Q8NFU1 | 318 |
| ZNF345 | OGFRL1 | Q5TC84 | 310 |
| ZNF345 | PTPN20 | Q4JDL3 | 308 |
| ZNF345 | CCDC18 | Q5T9S5 | 305 |
| ZNF345 | CIBAR1 | A1XBS5 | 302 |
| ZNF345 | DUS4L | O95620 | 296 |
| ZNF345 | SBNO1 | A3KN83 | 291 |
| ZNF345 | RWDD2B | P57060 | 287 |
| ZNF345 | RUNDC3B | Q96NL0 | 272 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF345 | RNPS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF250 | ZNF345 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFEMP2 | ZNF345 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF345 | DMWD | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMNA | ZNF345 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSC1 | ZNF345 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF345 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNPS1 | ZNF345 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF250 | ZNF345 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EFEMP2 | ZNF345 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF345 | serS | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): ZNF345 (Two-hybrid), ZNF345 (Two-hybrid), ZNF345 (Two-hybrid), ZNF345 (Two-hybrid), ZNF345 (Two-hybrid), ZNF345 (Affinity Capture-RNA), ZNF345 (Cross-Linking-MS (XL-MS)), ZNF345 (Affinity Capture-RNA)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
Diamond homologs: A8MQ14, O75290, Q14585, Q3SYV7, Q4R6C2, Q5R5Q6, Q6J6I6, Q6JLC9, Q6P9Y7, Q6PG37, Q7Z3V5, Q86UE3, Q8N141, Q8N7M2, Q8N9K5, Q8NA42, Q8NB42, Q8TAF7, Q95K52, Q969W8, Q96NG8, Q9HCL3, Q9Y6R6, P52738, A0A1W2PQL4, A2RRD8, A2VDP4, A2VDQ7, A6NHJ4, A8MTY0, A8MUV8, B4DX44, B4DXR9, E9PW05, O75820, P08042, P0CJ79, P10755, P16373, P16374
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 3 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
809 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36908327:CCTTA:C | donor_loss | 1.0000 |
| 19:36908328:CTTAC:C | donor_loss | 1.0000 |
| 19:36908329:TTAC:T | donor_loss | 1.0000 |
| 19:36908330:TA:T | donor_loss | 1.0000 |
| 19:36908331:A:AG | donor_loss | 1.0000 |
| 19:36908331:AC:A | donor_gain | 1.0000 |
| 19:36908332:C:G | donor_loss | 1.0000 |
| 19:36908332:CC:C | donor_gain | 1.0000 |
| 19:36908332:CCCA:C | donor_gain | 1.0000 |
| 19:36908335:A:AC | donor_gain | 1.0000 |
| 19:36908336:C:CC | donor_gain | 1.0000 |
| 19:36908371:T:TA | donor_gain | 1.0000 |
| 19:36872532:T:G | acceptor_gain | 0.9900 |
| 19:36876779:TTTCA:T | acceptor_loss | 0.9900 |
| 19:36876780:TTCA:T | acceptor_loss | 0.9900 |
| 19:36876781:TCAG:T | acceptor_loss | 0.9900 |
| 19:36876783:AGA:A | acceptor_loss | 0.9900 |
| 19:36876784:GACT:G | acceptor_gain | 0.9900 |
| 19:36892467:CAGAT:C | acceptor_gain | 0.9900 |
| 19:36892468:AGATC:A | acceptor_loss | 0.9900 |
| 19:36892469:GATCT:G | acceptor_loss | 0.9900 |
| 19:36892470:ATCTG:A | acceptor_loss | 0.9900 |
| 19:36892471:TCT:T | acceptor_loss | 0.9900 |
| 19:36892472:C:CA | acceptor_loss | 0.9900 |
| 19:36892472:C:CC | acceptor_gain | 0.9900 |
| 19:36892473:T:G | acceptor_loss | 0.9900 |
| 19:36907924:CTT:C | donor_loss | 0.9900 |
| 19:36907926:TACCT:T | donor_loss | 0.9900 |
| 19:36907927:A:C | donor_loss | 0.9900 |
| 19:36907928:C:CA | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000141647 (19:36857443 A>G), RS1000316464 (19:36849642 C>A,T), RS1000366600 (19:36890588 C>G,T), RS1000440391 (19:36890854 T>C), RS1000515009 (19:36857329 C>T), RS1000581958 (19:36876711 TC>T), RS1000659712 (19:36868641 T>TTG), RS1000729807 (19:36876056 T>C), RS1000803515 (19:36876357 C>G), RS1000917358 (19:36851158 TAG>T), RS1000964003 (19:36861842 G>A), RS1000995264 (19:36862246 G>A), RS1001085538 (19:36888437 C>G,T), RS1001188367 (19:36869374 GGT>G), RS1001224815 (19:36856441 G>A)
Disease associations
OMIM: gene MIM:621272 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002383_279 | Hematocrit | 5.000000e-10 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004348 | hematocrit |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, decreases methylation | 4 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation, affects cotreatment | 1 |
| methylselenic acid | increases expression | 1 |
| terbufos | increases methylation | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| sodium arsenite | affects methylation | 1 |
| methacrylaldehyde | affects cotreatment, decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | decreases methylation, affects cotreatment | 1 |
| Acrolein | affects cotreatment, decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Estradiol | decreases expression | 1 |
| Ozone | affects cotreatment, decreases expression | 1 |
| Parathion | increases methylation | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Testosterone | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.